# MicroVention

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/microvention

- Industry: Medical Devices & Equipment
- Headquarters: Aliso Viejo, US
- Website: www.microvention.com
- Total disclosed funding: $49M
- Latest round: Series D (Sep 4, 2003)
- Investors on record: 10

## About

MicroVention, Inc. is a medical device company specializing in innovative solutions for neurovascular interventions, particularly focused on treating and preventing strokes.MicroVention, Inc. is engaged in the development of neurovascular devices, headquartered in Aliso Viejo, US. Founded in 1997, the company has undergone strategic pivots to enhance its product offerings. MicroVention completed its latest funding round, a Series D, in September 2003, raising USD 10.00 mn from investors including A.G. Edwards and Sons and Advanced Technology Ventures.MicroVention specializes in neurovascular solutions designed to address hemorrhagic and ischemic strokes. Their key products include aspiration catheters, stentrievers, and carotid stents, aimed at improving patient outcomes. Noteworthy products such as the SOFIA™ Flow Plus Aspiration Catheter and FRED™ X Flow Diversion Device are part of their portfolio, serving healthcare providers predominantly across North America, Europe, and selected Asia-Pacific markets.MicroVention generates revenue through the direct sale of its neurovascular devices to healthcare institutions and professionals. Their revenue is primarily derived from B2B transactions, including the sale of leading products like the SOFIA™ 88 Catheter. The company's pricing strategy reflects the clinical value provided, with tailored contracts for healthcare institutions to ensure a consistent supply of their devices.MicroVention plans to leverage its recent Series D funding of USD 10.00 mn to enhance product development and expand market reach. The company is focused on launching new products in the neurovascular arena. Specific plans include increasing its market penetration in Europe and Asia-Pacific by 2025, aligning with continuous advancements in their device offerings and ensuring robust partnerships with healthcare providers.

## Funding rounds

- Series D, Sep 4, 2003, $10M — Advanced Technology Ventures, Delphi Ventures, US Venture Partners, Crosspoint Venture Partners, De Novo Ventures, A.G. Edwards and Sons, Asset Management
- Series D, Aug 27, 2002, $19M — Advanced Technology Ventures, Delphi Ventures, US Venture Partners, Crosspoint Venture Partners, De Novo Ventures, A.G. Edwards and Sons, EKO Asset Management Partners
- Series C, Aug 1, 2001, $13M — Advanced Technology Ventures, Delphi Ventures, Domain Associates, Crosspoint Venture Partners, De Novo Ventures
- Series B, Sep 15, 1999, $7.5M — Advanced Technology Ventures, Domain Associates, Crosspoint Venture Partners, Medicus Ventures

## Investors

- Advanced Technology Ventures (https://capitalatlas.ai/funds/advanced-technology-ventures) — Series B, Series C, Series D
- Domain Associates (https://capitalatlas.ai/funds/domain-associates) — Series B, Series C
- Crosspoint Venture Partners (https://capitalatlas.ai/funds/crosspoint-venture-partners) — Series B, Series C, Series D
- Medicus Ventures (https://capitalatlas.ai/funds/medicus-ventures) — Series B
- Delphi Ventures (https://capitalatlas.ai/funds/delphi-ventures) — Series C, Series D
- De Novo Ventures (https://capitalatlas.ai/funds/de-novo-ventures) — Series C, Series D
- US Venture Partners (https://capitalatlas.ai/funds/us-venture-partners) — Series D
- A.G. Edwards and Sons — Series D
- EKO Asset Management Partners — Series D
- Asset Management — Series D